Clinical Trial Update: Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 gene transfer trial delivering rAAVrh74.MCK.GALGT2 for Duchenne muscular dystrophy; the study is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• rAAVrh74.MCK.GALGT2

Snippet

Sponsor: Kevin Flanigan | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-04-25